0001214659-21-000673.txt : 20210120 0001214659-21-000673.hdr.sgml : 20210120 20210120181424 ACCESSION NUMBER: 0001214659-21-000673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faga Daniel CENTRAL INDEX KEY: 0001673528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 21539846 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-50973.xml PRIMARY DOCUMENT X0306 4 2021-01-15 0001576263 Mirati Therapeutics, Inc. MRTX 0001673528 Faga Daniel C/O MIRATI THERAPEUTICS 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Operating Officer Common Stock 2021-01-15 4 A false 7023 0.00 A 30638 D Employee Stock Option (Right to Buy) 214.47 2021-01-15 4 A false 10979 0 A 2031-01-14 Common Stock 10979 10979 D Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested. 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested. /s/ Vickie Reed, Attorney-in-Fact 2021-01-20